These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23797910)

  • 1. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
    Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
    J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening.
    Pelander A; Tyrkkö E; Ojanperä I
    Rapid Commun Mass Spectrom; 2009 Feb; 23(4):506-14. PubMed ID: 19142846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of four designer drugs and their major metabolites by liquid chromatography-mass spectrometry.
    Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 992():1-7. PubMed ID: 25939091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Haas C; Meyer MR; Fritschi G; Maurer HH
    J Mass Spectrom; 2009 Jun; 44(6):952-64. PubMed ID: 19241365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of 3,4-dimethylmethcathinone in blood and urine by liquid chromatography-tandem mass spectrometry in a fatal case.
    Usui K; Aramaki T; Hashiyada M; Hayashizaki Y; Funayama M
    Leg Med (Tokyo); 2014 Jul; 16(4):222-6. PubMed ID: 24780695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Mortelé O; Vervliet P; Gys C; Degreef M; Cuykx M; Maudens K; Covaci A; van Nuijs ALN; Lai FY
    J Pharm Biomed Anal; 2018 May; 153():158-167. PubMed ID: 29494888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
    Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
    Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
    Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of in vitro phase I metabolites of methamnetamine in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Hong YK; Kim YH; Lee JM; Yoo HH; Choi SO; Kang MS
    Int J Legal Med; 2021 Jul; 135(4):1471-1476. PubMed ID: 33928430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.
    Vikingsson S; Josefsson M; Gréen H
    J Anal Toxicol; 2015; 39(6):426-35. PubMed ID: 25957385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism.
    Kintz P; Richeval C; Jamey C; Ameline A; Allorge D; Gaulier JM; Raul JS
    Drug Test Anal; 2017 Jul; 9(7):1026-1033. PubMed ID: 27671107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of in vitro and in vivo human metabolites of the new psychoactive substance nitracaine by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Negreira N; Kinyua J; De Brabanter N; Maudens K; van Nuijs AL
    Anal Bioanal Chem; 2016 Jul; 408(19):5221-9. PubMed ID: 27185541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate.
    Pozo ÓJ; Ibáñez M; Sancho JV; Lahoz-Beneytez J; Farré M; Papaseit E; de la Torre R; Hernández F
    Drug Metab Dispos; 2015 Feb; 43(2):248-57. PubMed ID: 25468950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.